Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

Health experts have warned that back pain “that doesn’t go away with rest” could signal cancer. According to Cancer Research ...

To evaluate PSA levels and kinetic cutoffs to predict positive bone scans for men with non-metastatic castration-resistant prostate cancer (CRPC) from the Shared Equal Access Regional Cancer ...

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk ...

Prostate cancer is one of the most common types of cancer among men in the UK, and one of the most deadly. Here are the ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought. A new study led by researchers at the UCLA Health ...

A new study investigates the utility of whole-body magnetic resonance imaging for detecting lymph and bone metastases in those with high-risk prostate cancer. Share on Facebook. Opens in a new tab ...

The study, published in JAMA Network Open, found that nearly half of high-risk prostate cancer patients previously classified as nonmetastatic by conventional imaging actually have metastatic ...

Long focused on antioxidants, researchers are now exploring a new route to combat prostate cancer: pro-oxidants.

Prostate cancer is one of the most common cancers in men worldwide, primarily affecting older men. The prostate is a small, walnut-shaped gland located just below the bladder and in front of the ...

BBC Outnumbered star Hugh Dennis is sending out a message over prostate cancer. It comes after a Christmas special of the ...